Novel compounds are provided having enhanced affinity for a desired, preselected, target substance (a small molecule; a macromolecule such as a protein, a carbohydrate, a nucleic acid, a cell, a viral particle, etc.) by modification with chemical groups that allow these substances to form strong bonds, such as irreversible covalent bonds, with the desired target substance. These qualities of tight, specific binding are reminiscent of antibody-like affinity; hence the new substances are termed COBALT, an acronym for Covalent-Binding Antibody-Like Trap. The present invention includes a process wherein a target species is chosen and then, by synthetic chemical procedures and modifications, novel substances (COBALTs) are obtained that exhibit selective and covalent binding to the preselected target species. The applications of the COBALTs include diagnostic, analytical, therapeutic and industrial applications.
本发明提供了一种新型化合物,通过
化学基团的修饰,使这些物质与所需的、预选的目标物质(如小分子、蛋白质、
碳水化合物、核酸、细胞、病毒颗粒等)具有增强的亲和力,从而形成强大的结合,如不可逆的共价结合。这种紧密、特异性的结合特性类似于
抗体的亲和力;因此,这些新物质被称为COBALT,是Covalent-Binding Antibody-Like Trap的缩写。本发明包括一种过程,选定目标物种,然后通过合成
化学程序和修饰,获得表现出选择性和共价结合的新型物质(COBALT)。COBALTs的应用包括诊断、分析、治疗和工业应用。